185 related articles for article (PubMed ID: 8751328)
1. Estrogen and progesterone receptors and anti-gross cystic disease fluid protein 15 (BRST-2) fail to distinguish metastatic breast carcinoma from eccrine neoplasms.
Wallace ML; Longacre TA; Smoller BR
Mod Pathol; 1995 Dec; 8(9):897-901. PubMed ID: 8751328
[TBL] [Abstract][Full Text] [Related]
2. Mammary origin of metastases. Immunohistochemical determination.
Chaubert P; Hurlimann J
Arch Pathol Lab Med; 1992 Nov; 116(11):1181-8. PubMed ID: 1444749
[TBL] [Abstract][Full Text] [Related]
3. Estrogen and progesterone receptors in primary eccrine carcinoma.
Voytek TM; Ricci A; Cartun RW
Mod Pathol; 1991 Sep; 4(5):582-5. PubMed ID: 1661896
[TBL] [Abstract][Full Text] [Related]
4. Gross cystic disease fluid protein-15 in salivary gland tumors.
Swanson PE; Pettinato G; Lillemoe TJ; Wick MR
Arch Pathol Lab Med; 1991 Feb; 115(2):158-63. PubMed ID: 1992983
[TBL] [Abstract][Full Text] [Related]
5. Progesterone-binding cyst protein (PBCP = GCDFP-24) and steroid hormone receptors as markers of differentiation in breast cancer. Inverse relation of distribution in normal and malignant tissue of the same breast.
Søreide JA; Lea OA; Kvinnsland S
Anticancer Res; 1991; 11(3):1323-6. PubMed ID: 1888167
[TBL] [Abstract][Full Text] [Related]
6. [An immunohistochemical study of cutaneous tumors using an antibody to the breast cyst fluid protein (GCDFP-15)].
Komatsu T
Nihon Hifuka Gakkai Zasshi; 1989 Aug; 99(9):991-7. PubMed ID: 2689727
[TBL] [Abstract][Full Text] [Related]
7. Immunoreactivity for estrogen receptor protein in sweat gland tumors.
Swanson PE; Mazoujian G; Mills SE; Campbell RJ; Wick MR
Am J Surg Pathol; 1991 Sep; 15(9):835-41. PubMed ID: 1951842
[TBL] [Abstract][Full Text] [Related]
8. Estrogen-receptor protein in thyroid neoplasms. An immunohistochemical analysis of papillary carcinoma, follicular carcinoma, and follicular adenoma.
Diaz NM; Mazoujian G; Wick MR
Arch Pathol Lab Med; 1991 Dec; 115(12):1203-7. PubMed ID: 1768209
[TBL] [Abstract][Full Text] [Related]
9. [An immunohistochemical study of normal sweat glands using an antibody to the breast cyst fluid protein (GCDFP-15)].
Komatsu T; Tajima S; Nishikawa T
Nihon Hifuka Gakkai Zasshi; 1989 Aug; 99(9):985-9. PubMed ID: 2689726
[TBL] [Abstract][Full Text] [Related]
10. [Use of immunohistochemical markers in the diagnosis of carcinoma of the breast].
Bussolati G
Minerva Chir; 1988 Sep; 43(18 Suppl):5-7. PubMed ID: 3226595
[No Abstract] [Full Text] [Related]
11. Estrogen receptors in skin appendage tumors and extramammary Paget's disease.
Lloveras B; Googe PB; Goldberg DE; Bhan AK
Mod Pathol; 1991 Jul; 4(4):487-90. PubMed ID: 1656434
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemistry of GCDFP-24 and zinc alpha2 glycoprotein in benign sweat gland tumors.
Mazoujian G
Am J Dermatopathol; 1990 Oct; 12(5):452-7. PubMed ID: 2244662
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemistry of gross cystic disease fluid protein (GCDFP-15) in 65 benign sweat gland tumors of the skin.
Mazoujian G; Margolis R
Am J Dermatopathol; 1988 Feb; 10(1):28-35. PubMed ID: 2459984
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibody B72.3 immunostaining of breast carcinoma. Patterns of staining and relationship to mucin content and GCDFP-15 reactivity.
Soomro S; Shousha S
Arch Pathol Lab Med; 1992 Jan; 116(1):32-5. PubMed ID: 1370877
[TBL] [Abstract][Full Text] [Related]
15. [Hormone receptor status in breast cancer in comparison with histologic tumor type].
Kasch R; Meissner J; Haack D; Neumann S
Zentralbl Gynakol; 1987; 109(24):1493-6. PubMed ID: 2831683
[TBL] [Abstract][Full Text] [Related]
16. Gross cystic disease fluid protein-15 as a marker for breast cancer: immunohistochemical analysis of 690 human neoplasms and comparison with alpha-lactalbumin.
Wick MR; Lillemoe TJ; Copland GT; Swanson PE; Manivel JC; Kiang DT
Hum Pathol; 1989 Mar; 20(3):281-7. PubMed ID: 2542151
[TBL] [Abstract][Full Text] [Related]
17. Value of gross cystic disease fluid protein-15 in distinguishing metastatic breast carcinomas among poorly differentiated neoplasms involving the ovary.
Monteagudo C; Merino MJ; LaPorte N; Neumann RD
Hum Pathol; 1991 Apr; 22(4):368-72. PubMed ID: 2050370
[TBL] [Abstract][Full Text] [Related]
18. Recent advances and controversies concerning adnexal neoplasms.
Smith KJ; Skelton HG; Holland TT
Dermatol Clin; 1992 Jan; 10(1):117-60. PubMed ID: 1309688
[TBL] [Abstract][Full Text] [Related]
19. Monitoring of hormonal therapy in patients with metastatic breast carcinoma by plasma marker protein profiles.
Haagensen DE; Dilley WG; Cox CE; Giannola JE; Wells SA
Surg Forum; 1978; 29():162-4. PubMed ID: 401123
[TBL] [Abstract][Full Text] [Related]
20. [Cell receptors and proliferation markers in breast cancer].
Czerwenka KF; Schön HJ; Zeillinger R; Kubista E; Spona J
Gynakol Rundsch; 1989; 29 Suppl 2():400-1. PubMed ID: 2558992
[No Abstract] [Full Text] [Related]
[Next] [New Search]
